意大利COVID-19疫情期间脑血管事件住院量下降
意大利卒中组织纳入93个卒中单元,比较2020年3月与2019年3月脑血管事件住院及再灌注治疗情况。缺血性卒中、脑出血、短暂性脑缺血发作住院均下降,静脉溶栓减少,北部血管内治疗增加,住院下降与各地COVID-19发病率无相关。
要点
- 疫情期间缺血性卒中、脑出血及TIA住院量均较去年同期下降。
- 静脉溶栓治疗减少,血管内治疗总体不变、北部增加。
- 住院量下降与各地COVID-19发病率无相关性。
核心结论
- 意大利COVID-19疫情最严重期间,卒中或短暂性脑缺血发作住院量减少,静脉溶栓减少,血管内治疗不变且在疫情最严重地区增加。
研究设计与样本
- 意大利卒中组织多中心研究,涉及93个意大利卒中单元,比较2020年3月1日至31日与2019年同期住院资料。
主要发现
- 缺血性卒中由2019年2399例降至2020年1810例,住院率比0.75(95%CI 0.71-0.80,P<0.001)。
- 脑出血由400例降至322例,住院率比0.81(95%CI 0.69-0.93,P=0.004)。
- 短暂性脑缺血发作由322例降至196例,住院率比0.61(95%CI 0.51-0.73,P<0.001)。
- 静脉溶栓由531例(22.1%)降至345例(19.1%),率比0.86(95%CI 0.75-0.99,P=0.032)。
- 北部血管内治疗增加,率比1.61(95%CI 1.13-2.32,P=0.008)。
临床怎么用
- 疫情期间需关注卒中及TIA患者就医延迟与住院减少,保障再灌注治疗可及性。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: We aimed to investigate the rate of hospital admissions for cerebrovascular events and of revascularization treatments for acute ischemic stroke in Italy during the coronavirus disease 2019 (COVID-19) outbreak. METHODS: The Italian Stroke Organization performed a multicenter study involving 93 Italian Stroke Units. We collected information on hospital admissions for cerebrovascular events from March 1 to March 31, 2020 (study period), and from March 1 to March 31, 2019 (control period). RESULTS: Ischemic strokes decreased from 2399 in 2019 to 1810 in 2020, with a corresponding hospitalization rate ratio (RR) of 0.75 ([95% CI, 0.71-0.80] P<0.001); intracerebral hemorrhages decreased from 400 to 322 (hospitalization RR, 0.81 [95% CI, 0.69-0.93]; P=0.004), and transient ischemic attacks decreased from 322 to 196 (hospitalization RR, 0.61 [95% CI, 0.51-0.73]; P<0.001). Hospitalizations decreased in Northern, Central, and Southern Italy. Intravenous thrombolyses decreased from 531 (22.1%) in 2019 to 345 in 2020 (19.1%; RR, 0.86 [95% CI, 0.75-0.99]; P=0.032), while primary endovascular procedures increased in Northern Italy (RR, 1.61 [95% CI, 1.13-2.32]; P=0.008). We found no correlation (P=0.517) between the hospitalization RRs for all strokes or transient ischemic attack and COVID-19 incidence in the different areas. CONCLUSIONS: Hospitalizations for stroke or transient ischemic attacks across Italy were reduced during the worst period of the COVID-19 outbreak. Intravenous thrombolytic treatments also decreased, while endovascular treatments remained unchanged and even increased in the area of maximum expression of the outbreak. Limited hospitalization of the less severe patients and delays in hospital admission, due to overcharge of the emergency system by COVID-19 patients, may explain these data.
引用
- Sacco S, Ricci S, Ornello R, et al. Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy. Stroke. 2020. PMID: 33059543. doi:10.1161/STROKEAHA.120.031293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。